Journal article
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms
Behavioural brain research, Vol.154(1), pp.239-243
2004
Handle:
https://hdl.handle.net/2376/106307
PMID: 15302130
Abstract
Central administration of angiotensin IV (Ang IV) analogues attenuates scopolamine-induced amnesia. Ang IV mediates its effects by binding to a high affinity, binding site, AT
4 receptor, that has recently been identified as insulin regulated aminopeptidase (IRAP). The purpose of this study was to examine the effect of the distinct AT
4 ligand, LVV-hemorphin-7 (LVV-H7), on scopolamine-induced learning deficits, one which involves fear-conditioning and the other spatial learning. Rats were pretreated with an intracerebroventricular (ICV) dose of scopolamine hydrobromide followed by treatment with 1
nmol LVV-H7 or artificial cerebrospinal fluid (aCSF). During the acquisition phase of the water maze task, daily ICV infusions of 1
nmol of LVV-H7 25
min after scopolamine treatment produced marked improvement in both the latency and distance swum in order to locate the submerged platform using visual cues compared to animals treated with scopolamine only. In addition, the same dose of LVV-H7 attenuated the learning deficit observed for scopolamine-treated animals in the passive avoidance task. These studies clearly demonstrate that LVV-H7, like Ang IV, is a pharmacologically active AT
4 ligand that attenuates the deleterious effects of scopolamine on learning performance in two different behavioral paradigms.
Metrics
11 Record Views
Details
- Title
- Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms
- Creators
- Anthony L Albiston - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, AustraliaEric S Pederson - Program in Neuroscience, Washington State University, Pullman, WA 99164-6520, USAPeta Burns - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, AustraliaBrett Purcell - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, AustraliaJohn W Wright - Program in Neuroscience, Washington State University, Pullman, WA 99164-6520, USAJoseph W Harding - Program in Neuroscience, Washington State University, Pullman, WA 99164-6520, USAFrederick A Mendelsohn - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, AustraliaRichard S Weisinger - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, AustraliaSiew Yeen Chai - Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne, Parkville, Vic. 3010, Australia
- Publication Details
- Behavioural brain research, Vol.154(1), pp.239-243
- Academic Unit
- Psychology, Department of; Integrative Physiology and Neuroscience, Department of
- Publisher
- Elsevier B.V
- Identifiers
- 99900546934601842
- Language
- English
- Resource Type
- Journal article